fda warning letter bpc-157 peptide compounding safety Exciting news for peptides coming out of today's committee hearing! The FDA panel backs compounded BPC-157,

These extremely rare side effects include: Reactive thrombocytosis during the first week of use in megaloblastic anaemia Hypersensitivity reactions including: rash, itching, exanthema, antibodies to HYDR0XOCOBALAMIN-transcobalamin II Anaphylaxis Hypokalaemia Headache, paraesthesia, tremor Irregular heartbeat (arrhythmias secondary to hypokalaemia) Nausea Vomiting Diarrhoea Fever, chills, hot flushes, dizziness, malaise, pain and / or swelling at the injection site Acne Abnormal colouration of the urine (chromaturia) What should you not do after a B12 shot

Eat a meal or light snack before your appointment

2021;10:PMC8257309

GH/IGF-I regulation in obesitymechanisms and practical consequences in children and adults

2008;337:a425

Breakthrough technologies driving drug discovery Peptides Lab UK - Your Trusted Source for Research Peptides and Biomarker Testing in the UK At Peptides Lab UK, we specialise in providing high-quality research peptides and blood testing services designed to support scientific innovation, health optimisation, and performance monitoring